Performance studies and the manufacturer of GNS-active drugs.

Author(s)
Haller.J. Ward.J & Amrein, lt.
Year
Abstract

The fact that at present a large number of different methods are used to measure various aspects of driving performance indicates that no single method or combination of tests has been found which is generally agreed to be adequate for this purpose. Therefore national and international bodies, as well as manufacturers of drugs which may affect the Central Nervous System, would like guidelines to be developed concerning the measurement of driving performance impairment.

Request publication

10 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Publication

Library number
B 25327 (In: B 25301) /83.4/ IRRD 801402
Source

In: Drugs and driving : proceedings of the first international symposium on prescription drugs and driving performance, Vinkeveen, The Netherlands, 25-28 June 1984, p. 331-337, 1 tab.

Our collection

This publication is one of our other publications, and part of our extensive collection of road safety literature, that also includes the SWOV publications.